Ömer Özden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ömer Özden has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Murat Tanyildiz
Koç University School of Medicine, Department of Cardiac Intensive Care Unit, Istanbul, Türkiye
5 shared publications - Cemile Pehlivanoglu
Pediatric Nephrology Department, University of Health Sciences, Umraniye Training and Research Hospital, Istanbul, Turkey
3 shared publications - Ilmay Bilge
Pediatric Nephrology Department Koç University Faculty of Medicine Istanbul Turkey
3 shared publications - Başak Akyollu
Prof. Munci Kalayoglu, M.D. Organ Transplant Center, Koc University Hospital, Istanbul, Türkiye
2 shared publications - Cihan Karataş
Koc Univ Hosp, Dept Liver Transplantat, Istanbul, Turkiye
2 shared publications - Dilek Ertoy Baydar
Department of Pathology, Koc University, Istanbul, Türkiye
2 shared publications
Latest Publications
- 9 November 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-17
Pediatric living-donor kidney transplantation in infants and low-weight children: what have we learned so far?
- 9 November 2026
- Published by Springer Nature in Pediatric Nephrology
- p. 1-17
Pediatric living-donor kidney transplantation in infants and low-weight children: what have we learned so far?
- 4 November 2026
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
Platelet Transfusion Practices in the PICUs: Multicenter, Observational Study, in Türkiye and Northern Cyprus, 2024
Objectives: We aimed to describe the use of platelet transfusions among critically ill children managed in Türkiye in late 2024. Secondarily, we sought to determine these practices in relation to the 2022 Transfusion and Anemia Expertise Initiative-Control/Avoidance of Bleeding (TAXI-CAB) recommendations for critically ill pediatric patients. Design: Prospective study (October–December 2024). Setting: 22 PICUs in Türkiye and Northern Cyprus. Patients: Patients of 1 month to 18 years who received at least one platelet transfusion in the PICU. Interventions: None Measurement and Main Results: Out of 2693 PICU admissions, 200 patients (7.4%) received 577 platelet transfusions. Of the transfusions, 383 of 577 transfusions (66.4%) were for prophylaxis, most frequently for isolated thrombocytopenia (194/383, 50.7%). Regarding the transfusion threshold for prophylaxis, in the 194 cases of isolated thrombocytopenia, the median (interquartile range [IQR]) pretransfusion platelet count was 24 (IQR, 16–38) × 10 9 /L, which differed from the TAXI-CAB consensus statement guidance of less than 10 × 10 9 /L. Platelet transfusion, as opposed to not, was associated with 20-fold greater odds of 28-day mortality ( p < 0.001), and among the 200 patients receiving platelets, multivariable analysis showed that lower pretransfusion platelet count, support with invasive mechanical ventilation, and hospital-acquired infections collectively accounted for 34% of the variance in model performance for classifying 28-day mortality. Conclusions: Our 2024 national, multicenter PICU study across Türkiye and Northern Cyprus shows that around two-thirds of transfusion episodes were for prophylaxis, and multivariable logistic regression modeling identified patient factors associated with greater odds of 28-day mortality. The median pretransfusion threshold for isolated thrombocytopenia was around 20 × 10 9 /L, which is double the less than 10 × 10 9 /L in the 2022 TAXI-CAB consensus statement. Given the heterogeneity of critically ill patients and practice environments, understanding the reasons behind these practices may help inform future research and consensus recommendations.
- 4 November 2026
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
Platelet Transfusion Practices in the PICUs: Multicenter, Observational Study, in Türkiye and Northern Cyprus, 2024
Objectives: We aimed to describe the use of platelet transfusions among critically ill children managed in Türkiye in late 2024. Secondarily, we sought to determine these practices in relation to the 2022 Transfusion and Anemia Expertise Initiative-Control/Avoidance of Bleeding (TAXI-CAB) recommendations for critically ill pediatric patients. Design: Prospective study (October–December 2024). Setting: 22 PICUs in Türkiye and Northern Cyprus. Patients: Patients of 1 month to 18 years who received at least one platelet transfusion in the PICU. Interventions: None Measurement and Main Results: Out of 2693 PICU admissions, 200 patients (7.4%) received 577 platelet transfusions. Of the transfusions, 383 of 577 transfusions (66.4%) were for prophylaxis, most frequently for isolated thrombocytopenia (194/383, 50.7%). Regarding the transfusion threshold for prophylaxis, in the 194 cases of isolated thrombocytopenia, the median (interquartile range [IQR]) pretransfusion platelet count was 24 (IQR, 16–38) × 10 9 /L, which differed from the TAXI-CAB consensus statement guidance of less than 10 × 10 9 /L. Platelet transfusion, as opposed to not, was associated with 20-fold greater odds of 28-day mortality ( p < 0.001), and among the 200 patients receiving platelets, multivariable analysis showed that lower pretransfusion platelet count, support with invasive mechanical ventilation, and hospital-acquired infections collectively accounted for 34% of the variance in model performance for classifying 28-day mortality. Conclusions: Our 2024 national, multicenter PICU study across Türkiye and Northern Cyprus shows that around two-thirds of transfusion episodes were for prophylaxis, and multivariable logistic regression modeling identified patient factors associated with greater odds of 28-day mortality. The median pretransfusion threshold for isolated thrombocytopenia was around 20 × 10 9 /L, which is double the less than 10 × 10 9 /L in the 2022 TAXI-CAB consensus statement. Given the heterogeneity of critically ill patients and practice environments, understanding the reasons behind these practices may help inform future research and consensus recommendations.
- Open Access
- 17 August 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (8)
Diaphragmatic Atrophy After Pediatric Cardiac Surgery: Toward Integrated Monitoring
- 17 August 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (8)
Open AccessDiaphragmatic Atrophy After Pediatric Cardiac Surgery: Toward Integrated Monitoring
- Open Access
Early Prediction of Acute Kidney Injury Using the Furosemide Stress Test in Pediatric Cardiac Surgery Patients
Introduction: We evaluated the furosemide stress test as an early predictor of acute kidney injury following pediatric cardiac surgery, in comparison with the Kidney Disease: Improving Global Outcomes (KDIGO) diagnostic criteria. Materials and Methods: This single-centre retrospective study evaluated pediatric patients who underwent open cardiac surgery between March 2019 and September 2024 at Koç University Hospital. The evaluation included pre-operative, intra-operative, and postoperative variables; a two-hour assessment of urinary response to the first dose of furosemide upon admission to the intensive care unit; and rates of acute kidney injury. Results: A total of 254 patients were included, and 53 patients (20.8%) developed acute kidney injury according to KDIGO criteria. The mean furosemide stress test response was 9.86 ± 5.84 (median: 9.10) mL/kg/h in the non-AKI group and was significantly lower in the AKI group at 5.07 ± 4.73 (median: 3.33) mL/kg/h (p < 0.001). Receiver operating characteristic analysis demonstrated that the furosemide stress test has discriminative ability to predict acute kidney injury. The cut-off value was 6.104 mL/kg/h, and patients with a lower response had a higher risk of developing acute kidney injury. Sensitivity and specificity were 69.8% and 69.7%, respectively. Acute kidney injury was diagnosed at a median of 18 h using KDIGO criteria, whereas the furosemide stress test enabled earlier prediction of acute kidney injury risk at a median of 5 h. Conclusions: The findings support the potential clinical utility of the furosemide stress test in the early stages after pediatric cardiac surgery to predict acute kidney injury.
Open AccessEarly Prediction of Acute Kidney Injury Using the Furosemide Stress Test in Pediatric Cardiac Surgery Patients
Introduction: We evaluated the furosemide stress test as an early predictor of acute kidney injury following pediatric cardiac surgery, in comparison with the Kidney Disease: Improving Global Outcomes (KDIGO) diagnostic criteria. Materials and Methods: This single-centre retrospective study evaluated pediatric patients who underwent open cardiac surgery between March 2019 and September 2024 at Koç University Hospital. The evaluation included pre-operative, intra-operative, and postoperative variables; a two-hour assessment of urinary response to the first dose of furosemide upon admission to the intensive care unit; and rates of acute kidney injury. Results: A total of 254 patients were included, and 53 patients (20.8%) developed acute kidney injury according to KDIGO criteria. The mean furosemide stress test response was 9.86 ± 5.84 (median: 9.10) mL/kg/h in the non-AKI group and was significantly lower in the AKI group at 5.07 ± 4.73 (median: 3.33) mL/kg/h (p < 0.001). Receiver operating characteristic analysis demonstrated that the furosemide stress test has discriminative ability to predict acute kidney injury. The cut-off value was 6.104 mL/kg/h, and patients with a lower response had a higher risk of developing acute kidney injury. Sensitivity and specificity were 69.8% and 69.7%, respectively. Acute kidney injury was diagnosed at a median of 18 h using KDIGO criteria, whereas the furosemide stress test enabled earlier prediction of acute kidney injury risk at a median of 5 h. Conclusions: The findings support the potential clinical utility of the furosemide stress test in the early stages after pediatric cardiac surgery to predict acute kidney injury.
- 13 February 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (2) , e70281
A Case of ABO ‐Incompatible Kidney Transplant in an Infant Patient
Introduction: ABO‐incompatible kidney transplantation (ABOi‐KT) is now increasingly performed in adults and children to expand the living‐donor pool and address organ shortages. Case Presentation: We report the case of a 6‐month‐old girl with end‐stage renal disease due to congenital renal anomalies who underwent living‐donor ABOi kidney transplantation from her grandmother. Pretransplant antibody titers were low, and the procedure was carried out without any preconditioning treatment. Postoperative management included immunosuppression and supportive therapies, with gradual recovery of graft function. The patient was discharged with excellent renal function and remains clinically stable on postoperative Day 120. Conclusion: This case illustrates the unique “window of opportunity” in early infancy, when low isohemagglutinin levels allow successful ABOi transplantation without the need for extensive desensitization. It further emphasizes that, in the setting of organ shortage, ABOi kidney transplantation can be a safe and effective option for carefully selected pediatric patients and even in infants.
- 13 February 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (2) , e70281
A Case of ABO ‐Incompatible Kidney Transplant in an Infant Patient
Introduction: ABO‐incompatible kidney transplantation (ABOi‐KT) is now increasingly performed in adults and children to expand the living‐donor pool and address organ shortages. Case Presentation: We report the case of a 6‐month‐old girl with end‐stage renal disease due to congenital renal anomalies who underwent living‐donor ABOi kidney transplantation from her grandmother. Pretransplant antibody titers were low, and the procedure was carried out without any preconditioning treatment. Postoperative management included immunosuppression and supportive therapies, with gradual recovery of graft function. The patient was discharged with excellent renal function and remains clinically stable on postoperative Day 120. Conclusion: This case illustrates the unique “window of opportunity” in early infancy, when low isohemagglutinin levels allow successful ABOi transplantation without the need for extensive desensitization. It further emphasizes that, in the setting of organ shortage, ABOi kidney transplantation can be a safe and effective option for carefully selected pediatric patients and even in infants.
- Open Access
- 9 April 2025
- Published by Galenos Yayinevi in Turkish Journal of Pediatric Emergency and Intensive Care Medicine
Evaluation of the Patients Admitted to the Pediatric Emergency Department with Influenza Like Illness During 2009 Influenza A/H1N1 Pandemic Period
Evaluation of the Patients Admitted to the Pediatric Emergency Department with Influenza Like Illness During 2009 Influenza A/H1N1 Pandemic Period - Journal of Pediatric Emergency and Intensive Care Medicine
- 9 April 2025
- Published by Galenos Yayinevi in Turkish Journal of Pediatric Emergency and Intensive Care Medicine
Open AccessEvaluation of the Patients Admitted to the Pediatric Emergency Department with Influenza Like Illness During 2009 Influenza A/H1N1 Pandemic Period
Evaluation of the Patients Admitted to the Pediatric Emergency Department with Influenza Like Illness During 2009 Influenza A/H1N1 Pandemic Period - Journal of Pediatric Emergency and Intensive Care Medicine
- Open Access
- 19 February 2025
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 67 (1) , 90-100
Should we give priority to plasma exchange and hyperbaric oxygen treatment before deciding on amputation for severe crush injuries?
Background. The most common medical sequelae after earthquakes are crush injuries and syndromes that require urgent and well-organized care, which further complicates the approach in the face of overstretched resources. The 2023 Kahramanmaraş earthquake, with a magnitude of 7.7, was one of the largest disasters in Türkiye, affecting 11 cities with a population of about 13.5 million people and claiming more than 50,000 deaths. Approximately 4.6 million pediatric patients were affected, with over 500 children undergoing amputations. The overwhelming number of cases rendered further treatment efforts nearly unfeasible. Cases. Here we present three cases of severe crush injuries in which amputation was initially considered in both primary and our tertiary centers but was prevented by a protocol that included therapeutic plasma exchange (TPE) and intensive hyperbaric oxygen treatments (HBOT). Based on our review of the literature, this appears to be the first case series documenting the use of therapeutic plasma exchange (TPE) in the management of crush injury. Conclusion. In extremities at risk for amputation, TPE therapy is crucial to preventing disseminated intravascular coagulation, systemic inflammatory response syndrome, and the accompanying multiorgan failure. It has been shown that extremities at risk for amputation due to poor perfusion can be managed confidently during the safe recovery period of daily TPE therapy with frequent HBOT, anticoagulant and vasodilator treatments, frequent wound care to prevent the development of infection, prophylactic antibiotics, vacuum-assisted closure therapy, and debridement when necessary.
- 19 February 2025
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 67 (1) , 90-100
Open AccessShould we give priority to plasma exchange and hyperbaric oxygen treatment before deciding on amputation for severe crush injuries?
Background. The most common medical sequelae after earthquakes are crush injuries and syndromes that require urgent and well-organized care, which further complicates the approach in the face of overstretched resources. The 2023 Kahramanmaraş earthquake, with a magnitude of 7.7, was one of the largest disasters in Türkiye, affecting 11 cities with a population of about 13.5 million people and claiming more than 50,000 deaths. Approximately 4.6 million pediatric patients were affected, with over 500 children undergoing amputations. The overwhelming number of cases rendered further treatment efforts nearly unfeasible. Cases. Here we present three cases of severe crush injuries in which amputation was initially considered in both primary and our tertiary centers but was prevented by a protocol that included therapeutic plasma exchange (TPE) and intensive hyperbaric oxygen treatments (HBOT). Based on our review of the literature, this appears to be the first case series documenting the use of therapeutic plasma exchange (TPE) in the management of crush injury. Conclusion. In extremities at risk for amputation, TPE therapy is crucial to preventing disseminated intravascular coagulation, systemic inflammatory response syndrome, and the accompanying multiorgan failure. It has been shown that extremities at risk for amputation due to poor perfusion can be managed confidently during the safe recovery period of daily TPE therapy with frequent HBOT, anticoagulant and vasodilator treatments, frequent wound care to prevent the development of infection, prophylactic antibiotics, vacuum-assisted closure therapy, and debridement when necessary.
- 29 September 2023
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 19 (3) , 287-295
Evaluation of Ventilator-associated Pneumonia Approaches in Pediatric Intensive Care Units in Türkiye
- 29 September 2023
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 19 (3) , 287-295
Evaluation of Ventilator-associated Pneumonia Approaches in Pediatric Intensive Care Units in Türkiye
- 8 January 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (3) , 941-949
Fontan procedure in patients with preoperative mean pulmonary artery pressure over 15 mmHg
Background Several factors affect the long‐term outcome of Fontan procedure, but a high pulmonary artery pressure is still one of the most important limitation for proceeding to a Fontan circulation. Herein, we present our experience in Fontan patients with high preoperative pulmonary artery pressures. Methods A retrospective analysis was performed to evaluate Fontan patients with a preoperative pulmonary artery pressure >15 mmHg between 2009 and 2020. Sixteen patients were operated on with a mean preoperative pulmonary artery pressure of 17.5 ± 2.1 mmHg. Results Mean age at the time of Fontan procedure was 7.8 ± 5.6 years. All the patients had stage 2 cavopulmonary anastomosis before Fontan completion, with a mean interstage period of 4 ± 2.6 years. Fontan completion was achieved with a polytetrafluorethylene tubular conduit, two of which were intra‐extracardiac. Fenestration was performed in five (31%) cases. Postoperative pulmonary artery pressures and arterial oxygen saturation levels were 11.2 ± 2.8 and 97.8 ± 2 mmHg, respectively. Mean duration of pleural drainage was 3.9 ± 5.3 days. Any morbidity and mortality were not encountered during a mean follow‐up period of 4.8 ± 7.7 years. Conclusions The midterm results of stage 3 Fontan completion in patients with pulmonary artery >15 mmHg are encouraging. Not only the mean pulmonary artery pressure but also the pulmonary vascular resistance may be helpful in order to identify the high risk patients before Fontan completion.
- 8 January 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (3) , 941-949
Fontan procedure in patients with preoperative mean pulmonary artery pressure over 15 mmHg
Background Several factors affect the long‐term outcome of Fontan procedure, but a high pulmonary artery pressure is still one of the most important limitation for proceeding to a Fontan circulation. Herein, we present our experience in Fontan patients with high preoperative pulmonary artery pressures. Methods A retrospective analysis was performed to evaluate Fontan patients with a preoperative pulmonary artery pressure >15 mmHg between 2009 and 2020. Sixteen patients were operated on with a mean preoperative pulmonary artery pressure of 17.5 ± 2.1 mmHg. Results Mean age at the time of Fontan procedure was 7.8 ± 5.6 years. All the patients had stage 2 cavopulmonary anastomosis before Fontan completion, with a mean interstage period of 4 ± 2.6 years. Fontan completion was achieved with a polytetrafluorethylene tubular conduit, two of which were intra‐extracardiac. Fenestration was performed in five (31%) cases. Postoperative pulmonary artery pressures and arterial oxygen saturation levels were 11.2 ± 2.8 and 97.8 ± 2 mmHg, respectively. Mean duration of pleural drainage was 3.9 ± 5.3 days. Any morbidity and mortality were not encountered during a mean follow‐up period of 4.8 ± 7.7 years. Conclusions The midterm results of stage 3 Fontan completion in patients with pulmonary artery >15 mmHg are encouraging. Not only the mean pulmonary artery pressure but also the pulmonary vascular resistance may be helpful in order to identify the high risk patients before Fontan completion.